1
|
Liu W, Wu P, Song Z, Nie F, Zhang L, Lee D, Nakajima A, Xu J, Guo Y. Iridoids from Patrinia heterophylla and their anti-inflammatory activity. PHYTOCHEMISTRY 2023; 212:113720. [PMID: 37187247 DOI: 10.1016/j.phytochem.2023.113720] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 03/06/2023] [Revised: 05/04/2023] [Accepted: 05/09/2023] [Indexed: 05/17/2023]
Abstract
A phytochemical investigation led to the isolation of five undescribed compounds (1-5) from the methanol extract of the rhizomes and roots of Patrinia heterophylla. The structures and configurations of these compounds were characterized by HRESIMS, ECD, and NMR data analyses. These compounds were assayed for their anti-inflammatory potential using LPS-stimulated BV-2 cells, of which compound 4 showed strong nitric oxide (NO) inhibitory effects with an IC50 of 6.48 μM. The potential anti-inflammatory mechanism was examined utilizing Western blotting and molecular docking. Further in vivo anti-inflammatory experiments revealed that compound 4 inhibited the production of NO and reactive oxygen species in the zebrafish model.
Collapse
Affiliation(s)
- Wenhui Liu
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, And Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, PR China
| | - Peng Wu
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, And Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, PR China
| | - Ziteng Song
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, And Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, PR China
| | - Fan Nie
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, And Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, PR China
| | - Liang Zhang
- State Key Laboratory of Tea Plant Biology and Utilization, Anhui Agricultural University, Hefei, 230036, PR China.
| | - Dongho Lee
- Department of Biosystems and Biotechnology, College of Life Sciences and Biotechnology, Korea University, Seoul, 136-713, Republic of Korea
| | - Akira Nakajima
- Department of Applied Biology and Food Sciences, Faculty of Agriculture and Life Science, Hirosaki University, 3 Bunkyo-cho, Hirosaki, 036-8561, Japan
| | - Jing Xu
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, And Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, PR China.
| | - Yuanqiang Guo
- State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy, And Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin, 300350, PR China; Department of Applied Biology and Food Sciences, Faculty of Agriculture and Life Science, Hirosaki University, 3 Bunkyo-cho, Hirosaki, 036-8561, Japan.
| |
Collapse
|
2
|
Wang Y, Wu J, Wang D, Yang R, Liu Q. Traditional Chinese Medicine Targeting Heat Shock Proteins as Therapeutic Strategy for Heart Failure. Front Pharmacol 2022; 12:814243. [PMID: 35115946 PMCID: PMC8804377 DOI: 10.3389/fphar.2021.814243] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/13/2021] [Accepted: 12/21/2021] [Indexed: 11/13/2022] Open
Abstract
Heart failure (HF) is the terminal stage of multifarious heart diseases and is responsible for high hospitalization rates and mortality. Pathophysiological mechanisms of HF include cardiac hypertrophy, remodeling and fibrosis resulting from cell death, inflammation and oxidative stress. Heat shock proteins (HSPs) can ameliorate folding of proteins, maintain protein structure and stability upon stress, protect the heart from cardiac dysfunction and ameliorate apoptosis. Traditional Chinese medicine (TCM) regulates expression of HSPs and has beneficial therapeutic effect in HF. In this review, we summarized the function of HSPs in HF and the role of TCM in regulating expression of HSPs. Studying the regulation of HSPs by TCM will provide novel ideas for the study of the mechanism and treatment of HF.
Collapse
Affiliation(s)
- Yanchun Wang
- Shenyang the Tenth People’s Hospital, Shenyang, China
| | - Junxuan Wu
- Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China
| | - Dawei Wang
- Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan, China
- *Correspondence: Qing Liu, ; Dawei Wang, ; Rongyuan Yang,
| | - Rongyuan Yang
- The Second Clinical School of Medicine, Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine-Zhuhai Hospital, Zhuhai, China
- *Correspondence: Qing Liu, ; Dawei Wang, ; Rongyuan Yang,
| | - Qing Liu
- The Second Clinical School of Medicine, Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine-Zhuhai Hospital, Zhuhai, China
- *Correspondence: Qing Liu, ; Dawei Wang, ; Rongyuan Yang,
| |
Collapse
|
3
|
Natural iridoids from Patrinia heterophylla showing anti-inflammatory activities in vitro and in vivo. Bioorg Chem 2020; 104:104331. [PMID: 33142407 DOI: 10.1016/j.bioorg.2020.104331] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2020] [Revised: 09/13/2020] [Accepted: 09/28/2020] [Indexed: 01/19/2023]
Abstract
Inflammation, especially chronic inflammation, has been found to be closely related to the pathology of many diseases and the discovery of bioactive natural products to inhibit NO production is one of strategies to treat inflammation. In our continuous search for bioactive natural substances as potential anti-inflammatory agents, five new compounds (1-5) were extracted and purified from Patrinia heterophylla. The NMR and MS data analysis, along with electronic circular dichroism (ECD) calculations, led to the identification of these isolates, which were new iridoids. Using cell and zebrafish models, the in vitro and in vivo anti-inflammatory effects were conducted to evaluate the potency of anti-inflammation of these compounds. The preliminary mechanism was explored using molecular docking and Western blotting experiments.
Collapse
|
4
|
He X, Luan F, Zhao Z, Ning N, Li M, Jin L, Chang Y, Zhang Q, Wu N, Huang L. The Genus Patrinia: A Review of Traditional Uses, Phytochemical and Pharmacological Studies. THE AMERICAN JOURNAL OF CHINESE MEDICINE 2017; 45:637-666. [PMID: 28595500 DOI: 10.1142/s0192415x17500379] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/18/2022]
Abstract
The aim of the present review is to comprehensively outline the botanical description, traditional uses, phytochemistry, pharmacology and toxicology of Patrinia, and to discuss possible trends for the further study of medicinal plants from the genus Patrinia. The genus Patrinia plays an important role in Asian medicine for the treatment of erysipelas, conjunctival congestion with swelling and pain, peri-appendicular abscesses, lung carbuncle, dysentery, leucorrhea, and postpartum disease. More than 210 chemical constituents have been isolated and identified from Patrinia plants, especially P. scabiosaefolia Fisch., P. scabra Bunge, P. villosa Juss., P. heterophylla Bunge and P. rupestris(Pall.) Juss[Formula: see text] Of these compounds, triterpenoids and saponins, iridoids, flavonoids, and lignans are the major or active constituents. Both in vitro and in vivo studies have indicated that some monomer compounds and crude extracts from the genus Patrinia possess wide pharmacological activities, including antitumor, anti-inflammatory, antibacterial, and antiviral effects. In addition, they have been shown to have valuable and positive effects on the immune and nervous system in experimental animals. There are also some reports on the clinical uses and toxicity of these species. However, few reports have been published concerning the material identification or quality control of Patrinia species, and the clinical uses and toxic effects of these plants are relatively sparse. More attention must be given to these issues.
Collapse
Affiliation(s)
- Xirui He
- Honghui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an 710054, P. R. China
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, 710069, P. R. China
| | - Fei Luan
- Department of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, P. R. China
- Department of Pharmacy, Xi’an Weiyang District Hospital of Traditional Chinese Medicine, Xi’an, 710016, P. R. China
| | - Zefeng Zhao
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, 710069, P. R. China
| | - Ning Ning
- Honghui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an 710054, P. R. China
| | - Maoxing Li
- Department of Pharmacy, Gansu University of Chinese Medicine, Lanzhou 730000, P. R. China
- Department of Pharmacy, Lanzhou General Hospital of PLA, Key Laboratory of the Prevention and Treatment for Injury in Plateau of PLA, Lanzhou 730050, P. R. China
| | - Ling Jin
- Department of Pharmacy, Xi’an Weiyang District Hospital of Traditional Chinese Medicine, Xi’an, 710016, P. R. China
| | - Yu Chang
- Honghui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an 710054, P. R. China
| | - Qiang Zhang
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, 710069, P. R. China
| | - Ni Wu
- Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, Northwest University, Xi’an, 710069, P. R. China
| | - Linhong Huang
- Honghui Hospital, Xi’an Jiaotong University College of Medicine, Xi’an 710054, P. R. China
| |
Collapse
|
5
|
Understanding the Effectiveness of Natural Compound Mixtures in Cancer through Their Molecular Mode of Action. Int J Mol Sci 2017; 18:ijms18030656. [PMID: 28304343 PMCID: PMC5372668 DOI: 10.3390/ijms18030656] [Citation(s) in RCA: 164] [Impact Index Per Article: 23.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/15/2017] [Revised: 03/13/2017] [Accepted: 03/15/2017] [Indexed: 12/19/2022] Open
Abstract
Many approaches to cancer management are often ineffective due to adverse reactions, drug resistance, or inadequate target specificity of single anti-cancer agents. In contrast, a combinatorial approach with the application of two or more anti-cancer agents at their respective effective dosages can achieve a synergistic effect that boosts cytotoxicity to cancer cells. In cancer, aberrant apoptotic pathways allow cells that should be killed to survive with genetic abnormalities, leading to cancer progression. Mutations in apoptotic mechanism arising during the treatment of cancer through cancer progression can consequently lead to chemoresistance. Natural compound mixtures that are believed to have multiple specific targets with minimal acceptable side-effects are now of interest to many researchers due to their cytotoxic and chemosensitizing activities. Synergistic interactions within a drug mixture enhance the search for potential molecular targets in cancer cells. Nonetheless, biased/flawed scientific evidence from natural products can suggest false positive therapeutic benefits during drug screening. In this review, we have taken these factors into consideration when discussing the evidence for these compounds and their synergistic therapeutic benefits in cancer. While there is limited evidence for clinical efficacy for these mixtures, in vitro data suggest that these preparations merit further investigation, both in vitro and in vivo.
Collapse
|
6
|
The Use of Omic Technologies Applied to Traditional Chinese Medicine Research. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2017; 2017:6359730. [PMID: 28250795 PMCID: PMC5307000 DOI: 10.1155/2017/6359730] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/28/2016] [Revised: 10/23/2016] [Accepted: 10/24/2016] [Indexed: 12/28/2022]
Abstract
Natural products represent one of the most important reservoirs of structural and chemical diversity for the generation of leads in the drug development process. A growing number of researchers have shown interest in the development of drugs based on Chinese herbs. In this review, the use and potential of omic technologies as powerful tools in the modernization of traditional Chinese medicine are discussed. The analytical combination from each omic approach is crucial for understanding the working mechanisms of cells, tissues, organs, and organisms as well as the mechanisms of disease. Gradually, omic approaches have been introduced in every stage of the drug development process to generate high-quality Chinese medicine-based drugs. Finally, the future picture of the use of omic technologies is a promising tool and arena for further improvement in the modernization of traditional Chinese medicine.
Collapse
|
7
|
Suo T, Wang H, Li Z. Application of proteomics in research on traditional Chinese medicine. Expert Rev Proteomics 2016; 13:873-81. [DOI: 10.1080/14789450.2016.1220837] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
8
|
Chou HC, Chen JY, Lin DY, Wen YF, Lin CC, Lin SH, Lin CH, Chung TW, Liao EC, Chen YJ, Wei YS, Tsai YT, Chan HL. Identification of Up- and Down-Regulated Proteins in Pemetrexed-Resistant Human Lung Adenocarcinoma: Flavin Reductase and Calreticulin Play Key Roles in the Development of Pemetrexed-Associated Resistance. J Proteome Res 2015; 14:4907-20. [PMID: 26452990 DOI: 10.1021/acs.jproteome.5b00794] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Drug resistance is one of the major causes of cancer chemotherapy failure. In the current study, we used a pair of lung adenocarcinoma cell lines, A549 and the pemetrexed-resistant A549/PEM cells, as a model to monitor resistance-dependent cellular responses and identify potential therapeutic targets. By means of 2D differential gel electrophoresis (2D-DIGE) and matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS), we investigated the global protein expression alterations induced by pemetrexed treatment and resistance. The proteomic result revealed that pemetrexed exposure obviously altered the expression of 81 proteins in the A549 cells, whereas no significant response was observed in the similarly treated A549/PEM cells, hence implying an association between these proteins and the drug-specific response. Moreover, 72 proteins including flavin reductase and calreticulin demonstrated differential expression between the A549 and A549/PEM cells, indicating baseline resistance. Additional tests employed siRNA silencing, protein overexpression, cell viability analysis, and analysis of apoptosis to examine and confirm the potency of flavin reductase and calreticulin proteins in the development of pemetrexed resistance. In summary, by using a proteomic approach, we identified numerous proteins, including flavin reductase and calreticulin, involved in pemetrexed drug resistance-developing mechanisms. Our results provide useful diagnostic markers and therapeutic candidates for pemetrexed-resistant lung cancer treatment.
Collapse
Affiliation(s)
- Hsiu-Chuan Chou
- Department of Applied Science, National Hsinchu University of Education , No. 521, Nan-Da Road, Hsinchu 30014, Taiwan
| | - Jing-Yi Chen
- Department of Medical Science and Institute of Bioinformatics and Structural Biology, National Tsing Hua University , No. 101, Kuang-Fu Road Sec. 2, Hsinchu 30013, Taiwan
| | - Dai-Ying Lin
- Department of Medical Science and Institute of Bioinformatics and Structural Biology, National Tsing Hua University , No. 101, Kuang-Fu Road Sec. 2, Hsinchu 30013, Taiwan
| | - Yueh-Feng Wen
- Department of Medical Science and Institute of Bioinformatics and Structural Biology, National Tsing Hua University , No. 101, Kuang-Fu Road Sec. 2, Hsinchu 30013, Taiwan.,Department of Internal Medicine, National Taiwan University Hospital Hsinchu Branch , No. 25, Lane 442, Sec. 1, Jingguo Road, Hsinchu 30059, Taiwan
| | - Chi-Chen Lin
- Institute of Biomedical Science, National Chung-Hsing University , No. 250, Guoguang Road, Taichung 402, Taiwan.,Institute of Biomedical Science and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University , No. 250, Guoguang Road, Taichung 402, Taiwan.,Department of Medical Research and Education, Taichung Veterans General Hospital , No. 1650, Sec. 4, Taiwan Boulevard, Taichung 40705, Taiwan.,Division of Chest Medicine, Department of Internal Medicine, Changhua Christian Hospital , No. 480, Zhongzheng Road, Changhua 505, Taiwan
| | - Sheng-Hao Lin
- Institute of Biomedical Science, National Chung-Hsing University , No. 250, Guoguang Road, Taichung 402, Taiwan.,Division of Chest Medicine, Department of Internal Medicine, Changhua Christian Hospital , No. 480, Zhongzheng Road, Changhua 505, Taiwan
| | - Ching-Hsiung Lin
- Division of Chest Medicine, Department of Internal Medicine, Changhua Christian Hospital , No. 480, Zhongzheng Road, Changhua 505, Taiwan.,Department of Respiratory Care, College of Health Sciences, Chang Jung Christian University , No. 1, Changda Road, Tainan 71101, Taiwan.,School of Medicine, Chung Shan Medical University , No. 110, Sec. 1, Jianguo North Road, Taichung 40201, Taiwan
| | - Ting-Wen Chung
- Department of Medical Science and Institute of Bioinformatics and Structural Biology, National Tsing Hua University , No. 101, Kuang-Fu Road Sec. 2, Hsinchu 30013, Taiwan
| | - En-Chi Liao
- Department of Medical Science and Institute of Bioinformatics and Structural Biology, National Tsing Hua University , No. 101, Kuang-Fu Road Sec. 2, Hsinchu 30013, Taiwan
| | - Ying-Jen Chen
- Department of Medical Science and Institute of Bioinformatics and Structural Biology, National Tsing Hua University , No. 101, Kuang-Fu Road Sec. 2, Hsinchu 30013, Taiwan
| | - Yu-Shan Wei
- Department of Medical Science and Institute of Bioinformatics and Structural Biology, National Tsing Hua University , No. 101, Kuang-Fu Road Sec. 2, Hsinchu 30013, Taiwan
| | - Yi-Ting Tsai
- Department of Medical Science and Institute of Bioinformatics and Structural Biology, National Tsing Hua University , No. 101, Kuang-Fu Road Sec. 2, Hsinchu 30013, Taiwan
| | - Hong-Lin Chan
- Department of Medical Science and Institute of Bioinformatics and Structural Biology, National Tsing Hua University , No. 101, Kuang-Fu Road Sec. 2, Hsinchu 30013, Taiwan
| |
Collapse
|
9
|
Recent Advance in Applications of Proteomics Technologies on Traditional Chinese Medicine Research. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE 2015; 2015:983139. [PMID: 26557869 PMCID: PMC4629032 DOI: 10.1155/2015/983139] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/29/2015] [Revised: 08/04/2015] [Accepted: 08/04/2015] [Indexed: 12/25/2022]
Abstract
Proteomics technology, a major component of system biology, has gained comprehensive attention in the area of medical diagnosis, drug development, and mechanism research. On the holistic and systemic theory, proteomics has a convergence with traditional Chinese medicine (TCM). In this review, we discussed the applications of proteomic technologies in diseases-TCM syndrome combination researches. We also introduced the proteomic studies on the in vivo and in vitro effects and underlying mechanisms of TCM treatments using Chinese herbal medicine (CHM), Chinese herbal formula (CHF), and acupuncture. Furthermore, the combined studies of proteomics with other “-omics” technologies in TCM were also discussed. In summary, this report presents an overview of the recent advances in the application of proteomic technologies in TCM studies and sheds a light on the future global and further research on TCM.
Collapse
|
10
|
Research on the efficacy of Celastrus Orbiculatus in suppressing TGF-β1-induced epithelial-mesenchymal transition by inhibiting HSP27 and TNF-α-induced NF-κ B/Snail signaling pathway in human gastric adenocarcinoma. Altern Ther Health Med 2014; 14:433. [PMID: 25370696 PMCID: PMC4232669 DOI: 10.1186/1472-6882-14-433] [Citation(s) in RCA: 32] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2014] [Accepted: 10/27/2014] [Indexed: 01/13/2023]
Abstract
BACKGROUND Celastrus orbiculatus has been used as a folk medicine in China for the treatment of many diseases. In the laboratory, the ethyl acetate extract of Celastrus orbiculatus (COE) displays a wide range of anticancer functions. However, the inhibition of the metastasis mechanism of COE in gastric cancer cells has not been investigated so far. METHODS The present study was undertaken to determine if the anti-metastasis effect of COE was involved in inhibiting of epithelial-mesenchymal transition (EMT) of human gastric adenocarcinoma SGC-7901 cells. In vitro, a well-established experimental EMT model involving transforming growth factor β1 (TGF-β1) was applied. Viability, invasion and migration, protein and mRNA expression of tumor cells were analyzed by MTT assay, transwell assay, western blot and real-time PCR, respectively. The molecular targets of COE in SGC-7901 cells were investigated by two-dimensional gel electrophoresis (2-DE) and MALDI-TOF-TOF mass spectrometer. Overexpression of heat shock protein 27 (HSP27) was performed by transfected with the recombinant retroviral expression plasmid. In vivo, the anti-metastasis mechanisms of COE in the peritoneal gastric cancer xenograft model was explored and the effect was tested. RESULTS The non-cytostatic concentrations of COE effectively inhibited TGF-β1 induced EMT process in SGC-7901 cells, which is characterized by prevented morphological changes, increased E-cadherin expression and decreased Vimentin, N-cadherin expression. Moreover, COE inhibited invasion and migration induced by TGF-β1. Using a comparative proteomics approach, four proteins were identified as differently expressed, with HSP27 protein being one of the most significantly down-regulated proteins induced by COE. Moreover, the activation of nuclear factor κB (NF-κB)/Snail signaling pathway induced by tumor necrosis factor-α (TNF-α) was also attenuated under the pretreatment of COE. Interestingly, overexpression of HSP27 significantly decreases the inhibitory effect of COE on EMT and the NF-κB/Snail pathway. Furthermore, COE significantly reduced the number of peritoneal metastatic nodules in the peritoneal gastric cancer xenograft model. CONCLUSIONS Taken together, these results suggest that COE inhibits the EMT by suppressing the expression of HSP27, correlating with inhibition of NF-κB/Snail signal pathways in SGC-7901 cells. Based on these results, COE may be considered a novel anti-cancer agent for the treatment of metastasis in gastric cancer.
Collapse
|